GTG trade ideas
$GENE Bullish reversal in Genetic TechGenetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
Genetic Technologies LTD $GENE in heavy breakout patternSee notes on chart. Widening Bollinger Bands lead to heavy up-moves before a strong pull-back. Look for significant upside before a crash.
GENE great buying opportunityStart of a long term, high profit trend. Has continued short interest in the face of reg-sho forced buybacks (buy-ins), brokers are forcing people to cover at a loss and now have the stock on not able to borrow lists. At historically low levels with support and high bullish volume. Reward to risk favors the longs, a wise portfolio investment.
